| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 50.766 | 81.790 | 81.862 | 105.726 | 154.469 |
| Total Income - EUR | - | - | - | - | - | 50.769 | 81.790 | 81.862 | 105.912 | 156.200 |
| Total Expenses - EUR | - | - | - | - | - | 27.397 | 64.360 | 73.387 | 76.845 | 113.027 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 23.371 | 17.430 | 8.475 | 29.067 | 43.174 |
| Net Profit/Loss - EUR | - | - | - | - | - | 22.864 | 16.612 | 7.656 | 28.010 | 36.266 |
| Employees | - | - | - | - | - | 1 | 2 | 3 | 3 | 3 |
Check the financial reports for the company - Dr Silvia Adam S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 961 | 1.503 | 1.366 | 34.071 | 25.072 |
| Current Assets | - | - | - | - | - | 23.440 | 22.887 | 40.847 | 28.391 | 55.227 |
| Inventories | - | - | - | - | - | 0 | 295 | 296 | 975 | 0 |
| Receivables | - | - | - | - | - | 2.818 | 185 | 343 | 16.014 | 33.549 |
| Cash | - | - | - | - | - | 20.622 | 22.407 | 40.208 | 11.403 | 21.679 |
| Shareholders Funds | - | - | - | - | - | 22.905 | 19.906 | 7.711 | 32.641 | 50.314 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 1.496 | 4.483 | 34.501 | 29.821 | 29.986 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr Silvia Adam S.r.l.